perphenazine decanoate has been researched along with Chronic Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerlach, J; Larsen, EB | 1 |
| Aaes-Jørgensen, T; Gerlach, J; Kistrup, K; Larsen, NE | 1 |
2 other study(ies) available for perphenazine decanoate and Chronic Disease
| Article | Year |
|---|---|
Subjective experience of treatment, side-effects, mental state and quality of life in chronic schizophrenic out-patients treated with depot neuroleptics.
Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Female; Flupenthixol; Humans; Male; Middle Aged; Neurologic Examination; Perphenazine; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Sick Role | 1996 |
Perphenazine decanoate and cis(z)-flupentixol decanoate in maintenance treatment of schizophrenic outpatients. Serum levels at the minimum effective dose.
Topics: Adult; Chronic Disease; Dose-Response Relationship, Drug; Female; Flupenthixol; Humans; Male; Middle Aged; Outpatients; Perphenazine; Psychiatric Status Rating Scales; Schizophrenia | 1991 |